There is a debate about the classification of antipsychotic drugs: first generation vs second generation. And that it is a false distinction–created for marketing purposes.

I cropped the mp3 to just the interview:

Listen to The Lancet_3 January 2009

Other The Lancet podcasts:

http://podcast.thelancet.com/lancet.xml

Another related article: http://www.medicalnewstoday.com/articles/101945.php